Alicia C. Olivo is VP at NEOGENOMICS INC (NEO). They have made 3 open-market trades across 1 company since 2023, most recently 2026-05-11.
CIK 0001951869
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NEO | 93,567 | $1.5M |
Shares reported on the most recent Form 4, priced at the 2026-05-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NEO | SELL · 10b5-1 | 2025-11-25 | 2025-11-28 | $12.00 | $251K | +0.0% | +2.5% | -15.3% |
| NEO | SELL · 10b5-1 | 2025-10-16 | 2025-10-20 | $10.00 | $49K | -8.3% | -2.7% | +19.6% |
| NEO | SELL · 10b5-1 | 2024-11-15 | 2024-11-19 | $15.36 | $79K | +17.7% | +7.3% | -18.9% |
| NEO | SELL · 10b5-1 | 2024-08-15 | 2024-08-19 | $16.05 | $17K | -0.8% | -2.4% | -9.4% |
| NEO | SELL | 2024-05-15 | 2024-05-17 | $15.74 | $17K | -5.0% | -11.1% | +9.4% |
| NEO | SELL | 2024-02-15 | 2024-02-20 | $14.96 | $39K | -2.6% | -5.9% | -9.1% |
| NEO | SELL | 2023-11-17 | 2023-11-20 | $18.39 | $49K | -1.1% | +0.2% | -23.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.